Consonance Capital Management LP Keros Therapeutics, Inc. Transaction History

Consonance Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $26 Million - $38.8 Million	-887,885 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$42.4 - $70.11 $98,537 - $162,935	-2,324 Reduced 0.26%	887,885 $37.7 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $18 Million - $25.1 Million	333,114 Added 59.79%	890,209 $54.8 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $20.1 Million - $46.1 Million	557,095 New	557,095 $39.3 Million

168

27.5M

42.8K

1.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.67B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.